BFRA - Biofrontera AG

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
Currency in EUR. All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue12,0256,1304,1383,095.555
Cost of Revenue1,7151,6521,2361,116.686
Gross Profit10,3104,4782,9021,978.869
Operating Expenses
Research Development4,2254,6406,2044,534.181
Selling General and Administrative20,01911,6176,9297,091.645
Non Recurring----
Others----
Total Operating Expenses25,95917,90914,36912,742.512
Operating Income or Loss-13,934-11,779-10,231-9,646.957
Income from Continuing Operations
Total Other Income/Expenses Net-2,1681,200-972-1,074.021
Earnings Before Interest and Taxes-13,934-11,779-10,231-9,646.957
Interest Expense-1,133-1,207-1,168-1,149
Income Before Tax-16,102-10,579-11,203-10,720.978
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-16,102-10,579-11,203-10,720.978
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-16,102-10,579-11,203-10,720.978
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-16,102-10,579-11,203-10,720.978